LabCompass

Hamid Sayar

Medicine · Indiana University

OpenAlex ORCID
Acute Myeloid Leukemia ResearchHistone Deacetylase Inhibitors ResearchMultiple Myeloma Research and TreatmentsChronic Myeloid Leukemia TreatmentsNeutropenia and Cancer Infections

Publications

81

Citations

1,913

Est. group size

—

Recurring co-author estimate

Active years

26

Publishing since 2001

Research summary
AI-generated

Hamid Sayar conducts clinical research in blood cancers (hematologic malignancies), focusing on acute myeloid leukemia (AML) and related bone marrow disorders such as myelodysplastic syndromes (MDS). Much of the work involves clinical trials testing drug therapies, including oral azacitidine as maintenance treatment for AML, along with case reports of unusual disease presentations.

Acute myeloid leukemia (AML) treatment and clinical trialsMyelodysplastic syndromes (MDS)Drug therapies (e.g., oral azacitidine, checkpoint inhibitors)Myeloproliferative neoplasms and disparities in outcomesClinical case reports of rare blood-cancer presentations

Publication activity has been fairly steady at roughly 4-7 papers per year for most of the last decade, with a dip in the most recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.0/year recently
2017: 5 publications172018: 5 publications182019: 5 publications192020: 5 publications202021: 4 publications212022: 4 publications222023: 7 publications7232024: 1 publication242025: 2 publications252026: 1 publication26
Recent publications
Publishes in
  • Blood×9
  • Clinical Lymphoma Myeloma & Leukemia×3
  • American Journal of Hematology×2
  • Journal of Clinical Oncology×2
  • PMC×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile